All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission.

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

Regular tablets, like the iPad Mini, also make a great reading companion thanks to its bright display and access to multiple library apps. Ultimately, our testing considers all aspects of a ...

Xiaomi recently introduced the Xiaomi Pad 7 tablet in India, succeeding the Pad 6. This new model features an upgraded processor, enhanced connectivity options, and an updated operating system.

As per ET, the health ministry had sought the legal affairs department's view on its final draft notification on allowing small pharmaceutical companies more time for upgrading their facilities to ...

What’s old is new again. About five years into my tech reviewing journey, gaming tablets became a thing for about a year. Then they fizzled out faster than a cheap July 4th sparkler. But they ...

Passive use of tablets, such as for watching videos, can hinder creativity and imaginative play. Using tablets and smartphones as a go-to tactic to soothe upset children could also reduce ...

We would like to share some important news with you. After years of bringing you the latest insights, analysis and innovation news from the pharma industries, we have made the difficult decision to ...

Ascentage sold 7,325,000 American Depositary shares at $17.25 each. Credit: Andrey Zhuravlev via Getty Images. China-based biotech Ascentage Pharma has raised $126m in a US initial public offering ...

The answers will shape the industry’s fortunes this year, as BioPharma Dive details in the stories below. Read on for a look at what’s in store. Deerfield Management and J&J’s venture arm are among ...

After the initial impact of that lovely 14-inch display wears off, this is an underpowered Android tablet with a poor camera and no official accessories. It is a bit disappointing, as the build ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...